{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:15:23Z","timestamp":1794604523166,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Robot-assisted laparoscopic prostatectomy (RALP) is associated with hemodynamic shifts; patients on angiotensin receptor blockers (ARBs) are especially susceptible to intraoperative hypotension. We investigated whether induction with remimazolam reduces the intraoperative hypotension incidence and severity compared with propofol in this population. Herein, 112 hypertensive patients undergoing RALP who continued ARB therapy received remimazolam (0.2\u00a0mg\/kg) or propofol (1\u20131.5\u00a0mg\/kg) for anesthetic induction. The primary endpoint was hypotension occurrence (mean arterial pressure [MAP]\u2009&lt;\u200965 mmHg sustained for \u2265\u20091\u00a0min), assessed during the entire anesthesia and 15\u00a0min post-induction. Secondary endpoints included MAP\u2009&lt;\u200955 mmHg sustained for \u2265\u20091\u00a0min, time-weighted average (TWA)-MAP\u2009&lt;\u200965 mmHg or &lt;\u200955 mmHg, duration of MAP\u2009&lt;\u200965 mmHg, and required norepinephrine dose. The hypotension incidence did not differ significantly between groups during the entire anesthesia (87.5% vs. 89.3%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&gt;\u20090.999). During the entire anesthesia, no significant between-group differences were observed for MAP\u2009&lt;\u200955 mmHg for \u2265\u20091\u00a0min, TWA-MAP\u2009&lt;\u200965 mmHg or &lt;\u200955 mmHg, duration of MAP\u2009&lt;\u200965 mmHg, and required norepinephrine dose. Similarly, no significant between-group differences were observed during the 15\u00a0min after induction. Induction with remimazolam did not reduce intraoperative hypotension risk compared with low-dose propofol in patients undergoing RALP who continued ARB therapy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical trial registration number<\/jats:bold>\n                    : ClinicalTrials.gov (NCT06093971, 23\/10\/2023).\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-23469-y","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:41:09Z","timestamp":1763073669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intraoperative hypotension after remimazolam or propofol induction with sevoflurane maintenance in angiotensin II receptor blockers-treated patients: a randomized controlled trial"],"prefix":"10.1038","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06093971","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hye Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"23469_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/hypertensionaha.120.16667","volume":"78","author":"R Chen","year":"2021","unstructured":"Chen, R. et al. Comparative First-Line effectiveness and safety of ACE (Angiotensin-Converting Enzyme) inhibitors and angiotensin receptor blockers: A multinational cohort study. Hypertension 78, 591\u2013603. https:\/\/doi.org\/10.1161\/hypertensionaha.120.16667 (2021).","journal-title":"Hypertension"},{"key":"23469_CR2","doi-asserted-by":"publisher","unstructured":"Thompson, A. & AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. : A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 150, e351-e442, https:\/\/doi.org\/10.1161\/cir.0000000000001285 (2024).","DOI":"10.1161\/cir.0000000000001285"},{"key":"23469_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/anae.16308","volume":"79","author":"J Choi","year":"2024","unstructured":"Choi, J. et al. The association of withholding or continuing angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers on acute kidney injury after non-cardiac surgery. Anaesthesia 79, 937\u2013944. https:\/\/doi.org\/10.1111\/anae.16308 (2024).","journal-title":"Anaesthesia"},{"key":"23469_CR4","doi-asserted-by":"publisher","unstructured":"Halvorsen, S. et al. ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 43, 3826\u20133924, (2022). https:\/\/doi.org\/10.1093\/eurheartj\/ehac270 (2022).","DOI":"10.1093\/eurheartj\/ehac270"},{"key":"23469_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2024.17123","volume":"332","author":"M Legrand","year":"2024","unstructured":"Legrand, M. et al. Continuation vs discontinuation of Renin-Angiotensin system inhibitors before major noncardiac surgery: the Stop-or-Not randomized clinical trial. Jama 332, 970\u2013978. https:\/\/doi.org\/10.1001\/jama.2024.17123 (2024).","journal-title":"Jama"},{"key":"23469_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/j.jvca.2020.01.005","volume":"35","author":"U Yoon","year":"2021","unstructured":"Yoon, U. et al. Continuation of Angiotensin-Converting enzyme inhibitors on the day of surgery is not associated with increased risk of hypotension upon induction of general anesthesia in elective noncardiac surgeries. J. Cardiothorac. Vasc Anesth. 35, 508\u2013513. https:\/\/doi.org\/10.1053\/j.jvca.2020.01.005 (2021).","journal-title":"J. Cardiothorac. Vasc Anesth."},{"key":"23469_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/aln.0000000000001404","volume":"126","author":"PS Roshanov","year":"2017","unstructured":"Roshanov, P. S. et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cOhort evaluation prospective cohort. Anesthesiology 126, 16\u201327. https:\/\/doi.org\/10.1097\/aln.0000000000001404 (2017).","journal-title":"Anesthesiology"},{"key":"23469_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1213\/ane.0000000000002837","volume":"127","author":"C Hollmann","year":"2018","unstructured":"Hollmann, C., Fernandes, N. L. & Biccard, B. M. A systematic review of outcomes associated with withholding or continuing angiotensin-Converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery. Anesth. Analg. 127, 678\u2013687. https:\/\/doi.org\/10.1213\/ane.0000000000002837 (2018).","journal-title":"Anesth. Analg"},{"key":"23469_CR9","doi-asserted-by":"publisher","first-page":"111401","DOI":"10.1016\/j.jclinane.2024.111401","volume":"94","author":"J Kim","year":"2024","unstructured":"Kim, J. et al. Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study. J. Clin. Anesth. 94, 111401. https:\/\/doi.org\/10.1016\/j.jclinane.2024.111401 (2024).","journal-title":"J. Clin. Anesth."},{"key":"23469_CR10","doi-asserted-by":"publisher","first-page":"e038045","DOI":"10.1136\/bmjopen-2020-038045","volume":"10","author":"MT Pawlik","year":"2020","unstructured":"Pawlik, M. T. et al. Pronounced haemodynamic changes during and after robotic-assisted laparoscopic prostatectomy: a prospective observational study. BMJ Open. 10, e038045. https:\/\/doi.org\/10.1136\/bmjopen-2020-038045 (2020).","journal-title":"BMJ Open."},{"key":"23469_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinane.2014.01.014","volume":"26","author":"C Rosendal","year":"2014","unstructured":"Rosendal, C., Markin, S., Hien, M. D., Motsch, J. & Roggenbach, J. Cardiac and hemodynamic consequences during capnoperitoneum and steep Trendelenburg positioning: lessons learned from robot-assisted laparoscopic prostatectomy. J. Clin. Anesth. 26, 383\u2013389. https:\/\/doi.org\/10.1016\/j.jclinane.2014.01.014 (2014).","journal-title":"J. Clin. Anesth."},{"key":"23469_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi, M. et al. Efficacy and safety of remimazolam versus Propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J. Anesth. 34, 543\u2013553. https:\/\/doi.org\/10.1007\/s00540-020-02788-6 (2020).","journal-title":"J. Anesth."},{"key":"23469_CR13","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2147\/dddt.S384155","volume":"16","author":"Q Hu","year":"2022","unstructured":"Hu, Q., Liu, X., Wen, C., Li, D. & Lei, X. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des. Devel Ther. 16, 3957\u20133974. https:\/\/doi.org\/10.2147\/dddt.S384155 (2022).","journal-title":"Drug Des. Devel Ther."},{"key":"23469_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00540-023-03191-7","volume":"37","author":"S Czajka","year":"2023","unstructured":"Czajka, S., Putowski, Z. & Krzych, \u0141. Post-induction hypotension and intraoperative hypotension as potential separate risk factors for the adverse outcome: a cohort study. J. Anesth. 37, 442\u2013450. https:\/\/doi.org\/10.1007\/s00540-023-03191-7 (2023).","journal-title":"J. Anesth."},{"key":"23469_CR15","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja, A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 120, c179\u2013184. https:\/\/doi.org\/10.1159\/000339789 (2012).","journal-title":"Nephron Clin. Pract."},{"key":"23469_CR16","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/s41598-023-30506-1","volume":"13","author":"TL Kim","year":"2023","unstructured":"Kim, T. L. et al. Intraoperative mean arterial pressure and acute kidney injury after robot-assisted laparoscopic prostatectomy: a retrospective study. Sci. Rep. 13, 3318. https:\/\/doi.org\/10.1038\/s41598-023-30506-1 (2023).","journal-title":"Sci. Rep."},{"key":"23469_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12871-023-02188-9","volume":"23","author":"SW Song","year":"2023","unstructured":"Song, S. W., Kim, S., Park, J. H., Cho, Y. H. & Jeon, Y. G. Post-induction hypotension with remimazolam versus Propofol in patients routinely administered angiotensin axis blockades: a randomized control trial. BMC Anesthesiol. 23, 219. https:\/\/doi.org\/10.1186\/s12871-023-02188-9 (2023).","journal-title":"BMC Anesthesiol"},{"key":"23469_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12871-022-01899-9","volume":"22","author":"T Hojo","year":"2022","unstructured":"Hojo, T., Kimura, Y., Shibuya, M. & Fujisawa, T. Predictors of hypotension during anesthesia induction in patients with hypertension on medication: a retrospective observational study. BMC Anesthesiol. 22, 343. https:\/\/doi.org\/10.1186\/s12871-022-01899-9 (2022).","journal-title":"BMC Anesthesiol"},{"key":"23469_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2344\/anpr-67-02-02","volume":"67","author":"T Hojo","year":"2020","unstructured":"Hojo, T., Shibuya, M., Kimura, Y., Otsuka, Y. & Fujisawa, T. Refractory hypotension during general anesthesia despite withholding Telmisartan. Anesth. Prog. 67, 86\u201389. https:\/\/doi.org\/10.2344\/anpr-67-02-02 (2020).","journal-title":"Anesth. Prog"},{"key":"23469_CR20","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/eurheartj\/ehad716","volume":"45","author":"GL Ackland","year":"2024","unstructured":"Ackland, G. L. et al. Discontinuation vs. continuation of renin-angiotensin system Inhibition before non-cardiac surgery: the SPACE trial. Eur. Heart J. 45, 1146\u20131155. https:\/\/doi.org\/10.1093\/eurheartj\/ehad716 (2024).","journal-title":"Eur. Heart J."},{"key":"23469_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1213\/ane.0000000000005250","volume":"132","author":"A Gregory","year":"2021","unstructured":"Gregory, A. et al. Intraoperative hypotension is associated with adverse clinical outcomes after noncardiac surgery. Anesth. Analg. 132, 1654\u20131665. https:\/\/doi.org\/10.1213\/ane.0000000000005250 (2021).","journal-title":"Anesth. Analg"},{"key":"23469_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.bja.2018.04.036","volume":"121","author":"EM Wesselink","year":"2018","unstructured":"Wesselink, E. M., Kappen, T. H., Torn, H. M., Slooter, A. J. C. & van Klei, W. A. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br. J. Anaesth. 121, 706\u2013721. https:\/\/doi.org\/10.1016\/j.bja.2018.04.036 (2018).","journal-title":"Br. J. Anaesth."},{"key":"23469_CR23","first-page":"4594","volume":"12","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. The efficacy and safety of remimazolam Tosylate versus Propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am. J. Transl Res. 12, 4594\u20134603 (2020).","journal-title":"Am. J. Transl Res."},{"key":"23469_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgh.15188","volume":"36","author":"SH Chen","year":"2021","unstructured":"Chen, S. H. et al. Remimazolam tosilate in upper Gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial. J. Gastroenterol. Hepatol. 36, 474\u2013481. https:\/\/doi.org\/10.1111\/jgh.15188 (2021).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"23469_CR25","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1002\/prp2.851","volume":"9","author":"T Liu","year":"2021","unstructured":"Liu, T. et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double-blind, controlled trial. Pharmacol. Res. Perspect. 9, e00851. https:\/\/doi.org\/10.1002\/prp2.851 (2021).","journal-title":"Pharmacol. Res. Perspect."},{"key":"23469_CR26","doi-asserted-by":"publisher","first-page":"111580","DOI":"10.1016\/j.jclinane.2024.111580","volume":"98","author":"JW Ju","year":"2024","unstructured":"Ju, J. W. et al. Effect of remimazolam versus Propofol on hypotension after anesthetic induction in patients undergoing coronary artery bypass grafting: A randomized controlled trial. J. Clin. Anesth. 98, 111580. https:\/\/doi.org\/10.1016\/j.jclinane.2024.111580 (2024).","journal-title":"J. Clin. Anesth."},{"key":"23469_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/anae.16205","volume":"79","author":"J Fechner","year":"2024","unstructured":"Fechner, J. et al. Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial. Anaesthesia 79, 410\u2013422. https:\/\/doi.org\/10.1111\/anae.16205 (2024).","journal-title":"Anaesthesia"},{"key":"23469_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12871-023-01974-9","volume":"23","author":"R Sekiguchi","year":"2023","unstructured":"Sekiguchi, R. et al. Comparison of hemodynamics during induction of general anesthesia with remimazolam and target-controlled Propofol in middle-aged and elderly patients: a single-center, randomized, controlled trial. BMC Anesthesiol. 23, 14. https:\/\/doi.org\/10.1186\/s12871-023-01974-9 (2023).","journal-title":"BMC Anesthesiol"},{"key":"23469_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bja.2024.04.013","volume":"133","author":"R Takaki","year":"2024","unstructured":"Takaki, R. et al. Hypotension after general anaesthesia induction using remimazolam or Propofol in geriatric patients undergoing Sevoflurane anaesthesia with remifentanil: a single-centre, double-blind, randomised controlled trial. Br. J. Anaesth. 133, 24\u201332. https:\/\/doi.org\/10.1016\/j.bja.2024.04.013 (2024).","journal-title":"Br. J. Anaesth."},{"key":"23469_CR30","unstructured":"DIPRIVAN. FDA Approved package label.,   https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/019627s069lbl.pdf, (2022)."},{"key":"23469_CR31","doi-asserted-by":"publisher","first-page":"739552","DOI":"10.3389\/fphar.2022.739552","volume":"13","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. The impact of age on Propofol requirement for inducing loss of consciousness in elderly surgical patients. Front. Pharmacol. 13, 739552. https:\/\/doi.org\/10.3389\/fphar.2022.739552 (2022).","journal-title":"Front. Pharmacol."},{"key":"23469_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jclinane.2009.07.008","volume":"22","author":"M Weisenberg","year":"2010","unstructured":"Weisenberg, M. et al. Dose-dependent hemodynamic effects of Propofol induction following brotizolam premedication in hypertensive patients taking angiotensin-converting enzyme inhibitors. J. Clin. Anesth. 22, 190\u2013195. https:\/\/doi.org\/10.1016\/j.jclinane.2009.07.008 (2010).","journal-title":"J. Clin. Anesth."},{"key":"23469_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12871-024-02578-7","volume":"24","author":"SH Choi","year":"2024","unstructured":"Choi, S. H., Min, K. T., Park, E. K. & Park, S. Comparison of hypotension incidence between remimazolam and Propofol in patients with hypertension undergoing neurosurgery: prospective, randomized, single-blind trial. BMC Anesthesiol. 24, 198. https:\/\/doi.org\/10.1186\/s12871-024-02578-7 (2024).","journal-title":"BMC Anesthesiol"},{"key":"23469_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bja.2022.02.040","volume":"129","author":"D Chae","year":"2022","unstructured":"Chae, D., Kim, H. C., Song, Y., Choi, Y. S. & Han, D. W. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study. Br. J. Anaesth. 129, 49\u201357. https:\/\/doi.org\/10.1016\/j.bja.2022.02.040 (2022).","journal-title":"Br. J. Anaesth."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23469-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23469-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23469-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:07:44Z","timestamp":1763100464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23469-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23469"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23469-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39805"}}